Pharmaceutical preparations company · DE · FY ends Dec · Revenue $634M · 6.61% margin · $30M FCF
Operating margin is thin at 6.61%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 20.0%, still solid.
Net debt of $149M represents 5.0x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$634M
▲ +20.0% YoY
Net Income (TTM)
-$27M
▲ +51.7% YoY
Op. Margin
6.61%
▲ +1.9pp YoY
ROIC
4.89%
▲ +1.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$30M
▲ +179.7% YoY
Op. Cash Flow (TTM)
$33M
▲ +197.8% YoY
Net Debt
$149M
Cash & Equiv.
$294M
5Y CAGR: +19.4%
Continue Research